Diagnostic Startups Take on Growing Threat of Antibiotic-Resistant Bugs
January 14 2020

DZD featured in WSJ review of emerging diagnostic companies

Read More
Genomics Links Fecal Transplant Recipient Infections to Drug-Resistant E. coli Donor
October 31 2019

EpiXact uses sequencing to confirm cause of patient death in a clinical trial with wide ranging implications

Read More
HBS Impact – Advancing Diagnostics That Can Save Lives
September 1 2019

DZD featured in Harvard Business School alumni publication on Life Lab ventures

Read More
AI Algorithm to Fight HAI Gets Support with NIH Award
July 10 2019

DZD funding award for hospital-acquired infection technology reviewed by HCIT

Read More
DZD Wins $224K SBIR Grant to Fund HAI Outbreak Analysis Tool
July 10 2019

Award funds development of algorithm for detecting hospital acquired infections from large scale genomic datasets

Read More
BioWorld MedTech Features EpiXact® Launch
June 7 2019

Reporter Liz Hollis profiles DZD plans for hospital acquired infection service

Read More
Top